Cross-Presentation, Dendritic Cells, Tolerance and Immunity

Dendritic cells and the control of immunity

Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,496

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137

Tolerance, Danger, and the Extended Family

Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848

T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.

Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.2.389 · Cited by 2,501

IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE

Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,443

Innate Immunity: The Virtues of a Nonclonal System of Recognition

Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,350

Alternative processing for MHC class I presentation by immature and CpG‐activated dendritic cells

Chen, L., & Jondal, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324359 · Cited by 24

Cross-Presentation of Listeria -Derived CD8 T Cell Epitopes Requires Unstable Bacterial Translation Products

Janda, J., Schöneberger, P., Škoberne, M., Messerle, M., Rüssmann, H., & Geginat, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5644 · Cited by 24

Dendritic Cell–Dead Cell Interactions: Implications and Relevance for Immunotherapy

Fonteneau, J., Larsson, M., & Bhardwaj, N. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200107000-00005 · Cited by 24

Immune-Complex Mimics as a Molecular Platform for Adjuvant-Free Vaccine Delivery

Pepponi, I., Stylianou, E., van Dolleweerd, C. J., Diogo, G. R., Paul, M. J., Drake, P. M. W., K‐C., J., & Reljić, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060855 · Cited by 23

Polyfunctional Type-1, -2, and -17 CD8+ T Cell Responses to Apoptotic Self-Antigens Correlate with the Chronic Evolution of Hepatitis C Virus Infection

Franceschini, D., Porto, P. D., Piconese, S., Trella, E., Accapezzato, D., Paroli, M., Morrone, S., Piccolella, E., Spada, E., Mele, A., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002759 · Cited by 23

Corpse disposal after apoptosis

Rovere, P. Q., & Dumitriu, I. E. (2003) · APOPTOSIS · doi:10.1023/a:1025538324077 · Cited by 23

Reprogramming Immune Responses: Enabling Cellular Therapies and Regenerative Medicine

Down, J. D., & White‐Scharf, M. E. (2003) · Stem Cells · doi:10.1634/stemcells.21-1-21 · Cited by 23

Adoptive Immunotherapy for Malignant Glioma

Mitchell, D. A., Fecci, P. E., & Sampson, J. H. (2003) · The Cancer Journal · doi:10.1097/00130404-200305000-00004 · Cited by 23

Inhibition of murine GVHD by PEN110 treatment

Fast, L. D., DiLeone, G., Edson, C. M., & Purmal, A. A. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00212.x · Cited by 23

Principles of immunotherapy

Liebelt, B. D., Finocchiaro, G., & Heimberger, A. B. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802997-8.00010-4 · Cited by 23

Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis

Sasaki, I., Kato, T., Hemmi, H., Fukuda‐Ohta, Y., Wakaki-Nishiyama, N., Yamamoto, A., & Kaisho, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857954 · Cited by 22

Autologous and MHC class I–negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma

Curti, A., Parenza, M., & Colombo, M. P. (2002) · Blood · doi:10.1182/blood-2002-03-0991 · Cited by 22

DNA vaccines and apoptosis: to kill or not to kill?

Leitner, W. W., & Restifo, N. P. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19069 · Cited by 22

Effective tumor immunotherapy: start the engine, release the brakes, step on the gas pedal,...and get ready to face autoimmunity.

Tirapu, I., Mazzolini, G. D., Rodrı́guez-Calvillo, M., Arina, A., Palencia, B., Gabari, I., & Melero, I. (2002) · PubMed · Cited by 22

Danger, death and DNA vaccines

Bergmann‐Leitner, E. S., & Leitner, W. W. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2003.11.015 · Cited by 22

Translating cell biology in vitro to immunity in vivo

Boes, M. L., & Ploegh, H. L. (2004) · Nature · doi:10.1038/nature02762 · Cited by 22

CD8+ T-cell priming regulated by cytokines of the innate immune system

Stäger, S., & Kaye, P. M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.003 · Cited by 22

Tumor Vaccines

Stevenson, F. K., Rice, J., & Zhu, D. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)82002-9 · Cited by 22

CD5 on dendritic cells regulates CD4+ and CD8+ T cell activation and induction of immune responses

Li, H., Burgueño-Bucio, E., Xu, S., Das, S., Olguín‐Alor, R., Elmets, C. A., Athar, M., Raman, C., Soldevila, G., & Xu, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222301 · Cited by 24

Antigen Controls IL-7Rα Expression Levels on CD8 T Cells during Full Activation or Tolerance Induction

Hammerbeck, C. D., & Mescher, M. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2107 · Cited by 21

Dose dependence of oral tolerance to nickel

Wu, X., Roelofs-Haarhuis, K., Zhang, J., Nowak, M., Layland, L. E., Jermann, E., & Gleichmann, E. (2007) · International Immunology · doi:10.1093/intimm/dxm066 · Cited by 21

Presentation of self-antigens on MHC class II molecules during dendritic cell maturation

Zwickey, H. L., Unternaehrer, J., & Mellman, I. (2005) · International Immunology · doi:10.1093/intimm/dxh363 · Cited by 21

Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes

Lu, Z., & Ghazizadeh, S. (2005) · Experimental Dermatology · doi:10.1111/j.1600-0625.2005.00351.x · Cited by 21

Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand

Spencer, C. T., Gilchuk, P., Dragovic, S. M., & Joyce, S. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32833c1552 · Cited by 20

Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8+ T cells in vitro and in vivo

Fischer, R. T., Turnquist, H. R., Wang, Z., Beer–Stolz, D., & Thomson, A. W. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.05.001 · Cited by 20

Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies

Li, B., Simmons, A. D., Du, T., Lin, C. Y.-C., Москаленко, М., Gonzalez-Edick, M., VanRoey, M. J., & Jooss, K. U. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.008 · Cited by 20

Simultaneous enhancement of cellular and humoral immunity by the high salt formulation of Al(OH)3 adjuvant

Luo, M., Shao, B., Yu, J., Liu, T., Liang, X., Lu, L., Ye, T., He, Z., Xiao, H., & Wei, X. (2017) · Cell Research · doi:10.1038/cr.2017.14 · Cited by 20

IL-15 Serves as a Costimulator in Determining the Activity of Autoreactive CD8 T Cells in an Experimental Mouse Model of Graft-versus-Host-Like Disease

Miyagawa, F., Tagaya, Y., Kim, B., Patel, H. J., Ishida, K., Ohteki, T., Waldmann, T. A., & Katz, S. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1109 · Cited by 20

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes

Straten, P. T., Dahl, C., Schrama, D., Pedersen, L. Ø., Andersen, M. H., Seremet, T., Bröcker, E., Guldberg, P., & Becker, J. C. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0023-8 · Cited by 20

Dissection of cytotoxic and helper T cell responses

Schepers, K., Arens, R., & Schumacher, T. N. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5266-1 · Cited by 20

Heat Shock Fusion Protein gp96‐Ig Mediates Strong CD8 CTL Expansion in vivo

Štrbo, N., Yamazaki, K., Lee, K. P., Rukavina, D., & Podack, E. R. (2002) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2002.01118.x · Cited by 20

Viral genes as oncolytic agents for cancer therapy

Gupta, S. K., Gandham, R. K., Sahoo, A. P., & Tiwari, A. K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1782-1 · Cited by 19

A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants

Berguer, P. M., Alzogaray, V., Rossi, A. H., Mundiñano, J., Piazzón, I., & Goldbaum, F. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045705 · Cited by 19

Innate immune receptors for cross-presentation: The expanding role of NLRs

Corridoni, D., & Simmons, A. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.028 · Cited by 20

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Sanborn, R. E., Ross, H. J., Aung, S., Acheson, A. K., Moudgil, T. L., Puri, S., Hilton, T. L., Fisher, B. K., Coffey, T. S., Paustian, C. C., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0306-6 · Cited by 19

Equivalent stimulation of naive and memory CD8 T cells by DNA vaccination: a dendritic cell‐dependent process

Bedoui, S., Davey, G. M., Lew, A. M., & Heath, W. R. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2008.105 · Cited by 19

Monoclonal Antibodies Targeted Against Melanoma and Ovarian Tumors Enhance Dendritic Cell-Mediated Cross-Presentation of Tumor-Associated Antigens and Efficiently Cross-Prime CD8+ T Cells

Cioca, D., Deak, E., Cioca, F., & Păunescu, V. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000175496.51594.8b · Cited by 19

Surrogate Tumor Antigen Vaccination Induces Tumor-Specific Immunity and the Rejection of Spontaneous Metastases

Lewis, J. D., Shearer, M. H., Kennedy, R. C., & Bright, R. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2874 · Cited by 19

T cell priming by tissue-derived dendritic cells: New insights from recent murine studies

Sillé, F. C. M., Visser, A., & Boes, M. L. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.10.004 · Cited by 19

Glial grafting for demyelinating disease

Tepavčević, V., & Blakemore, W. F. (2005) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1700 · Cited by 18

Changes in dendritic cell migration and activation during SIV infection suggest a role in initial viral spread and eventual immunosuppression

Barratt‐Boyes, S. M., Zimmer, M. I., & Harshyne, L. A. (2002) · Journal of Medical Primatology · doi:10.1034/j.1600-0684.2002.t01-1-02005.x · Cited by 19

The proliferative response of CD4 T cells to steady-state CD8+ dendritic cells is restricted by post-activation death

Rizzitelli, A., Hawkins, E. D., Todd, H. F., Hodgkin, P. D., & Shortman, K. (2006) · International Immunology · doi:10.1093/intimm/dxh382 · Cited by 19

Prostate-specific antigen vaccines for prostate cancer

Hörig, H., Lee, C. S. D., & Kaufman, H. L. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.4.395 · Cited by 19

Liposome-Coupled Peptides Induce Long-Lived Memory CD8+ T Cells Without CD4+ T Cells

Taneichi, M., Tanaka, Y., Kakiuchi, T., & Uchida, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015091 · Cited by 18

DNA-encapsulated magnesium phosphate nanoparticles elicit both humoral and cellular immune responses in mice

Bhakta, G., Nurcombe, V., Maitra, A., & Shrivastava, A. (2014) · Results in Immunology · doi:10.1016/j.rinim.2014.04.001 · Cited by 18

Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy

Peng, T., Xu, T., & Liu, X. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2086940 · Cited by 19

Adenovirus-Based Immunotherapy of Cancer: Promises to Keep

de Gruijl, T. D., & van de Ven, R. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-398342-8.00006-9 · Cited by 18

Effector Lymphocytes in Islet Cell Autoimmunity

Santamaría, P. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1025156413404 · Cited by 18

Regulated Gene Expression in Gene Therapy

Zoltick, P., & Wilson, J. M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb11360.x · Cited by 21

Regulatory T Cell–Mediated Transplantation Tolerance

Bharat, A., Fields, R. C., & Mohanakumar, T. (2006) · Immunologic Research · doi:10.1385/ir:33:3:195 · Cited by 18

Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies

Schott, M., & Seißler, J. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00033-x · Cited by 18

Système immunitaire et tumeurs

Terme, M., & Tanchot, C. (2017) · Annales de Pathologie · doi:10.1016/j.annpat.2016.12.004 · Cited by 17

Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins

Cai, L., Zhang, J., Zhu, R., Shi, W., Xia, X., Edwards, M., Finch, W., Coombs, A., Gao, J., Chen, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20407 · Cited by 17

Targeting Cross-Presentation as a Route to Improve the Efficiency of Peptide-Based Cancer Vaccines

Wylie, B., Ong, F., Belhoul-Fakir, H., Priebatsch, K., Bogdawa, H., Stirnweiss, A., Watt, P., Cunningham, P., Stone, S. R., & Waithman, J. (2021) · Cancers · doi:10.3390/cancers13246189 · Cited by 16

Development of a cytotoxic T-lymphocyte-based, broadly protective influenza vaccine

Uchida, T. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00273.x · Cited by 17

Effect of Foot-and-Mouth Disease Virus Infection on the Frequency, Phenotype and Function of Circulating Dendritic Cells in Cattle

Sei, J. J., Waters, R. A., Kenney, M., Barlow, J., & Golde, W. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152192 · Cited by 17

Role of Interleukin-2 and Herpes Simplex Virus 1 in Central Nervous System Demyelination in Mice

Mott, K. R., Zandian, M., Allen, S. J., & Ghiasi, H. (2013) · Journal of Virology · doi:10.1128/jvi.02241-13 · Cited by 17

Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells.

Castiglioni, P., Martin‐Fontecha, A., Milan, G., Tomajer, V., Magni, F., Michaëlsson, J., Rugarli, C., Rosato, A., & Bellone, M. (2002) · PubMed · Cited by 17

Dendritic Cells and Immunotherapy for Cancer

Chang, D., & Dhodapkar, M. V. (2003) · International Journal of Hematology · doi:10.1007/bf02986611 · Cited by 17

Chapter 2 New Insights into the Roles of Dendritic Cells in Intestinal Immunity and Tolerance

Cerovic, V., McDonald, V., Nassar, M. A., Paulin, S. M., MacPherson, G. G., & Milling, S. W. F. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01602-x · Cited by 16

Nanogram Doses of Alum-Adjuvanted HBs Antigen Induce Humoral Immune Response in Mice When Orally Administered

Kapusta, J., Pniewski, T., Wojciechowicz, J., Bociąg, P., & Płucienniczak, A. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0065-2 · Cited by 16

The Role of Inflammation in the Generation and Maintenance of Memory T Cells

Butler, N. S., & Harty, J. T. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_4 · Cited by 16

Synthetic and natural non-live vectors: rationale for their clinical development in cancer vaccine protocols

Tartour, É., Benchetrit, F., Haicheur, N., Adotévi, O., & Fridman, W. H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00385-7 · Cited by 16

Lymphocyte Activation Gene-3 Fusion Protein Increases the Potency of a Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy

Li, B., VanRoey, M. J., Triebel, F., & Jooss, K. U. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5200 · Cited by 16

Activation and Evasion of Inflammasomes by Yersinia

Philip, N. H., Zwack, E. E., & Brodsky, I. E. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_4 · Cited by 17

Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells

Han, S., Song, Y., Lee, Y., Lee, Y.-R., Lee, C., Cho, K., & Kim, K. (2005) · Cytokine · doi:10.1016/j.cyto.2005.08.002 · Cited by 16

Differentiation of human dendritic cells from monocytes in vitro using granulocyte-macrophage colony stimulating factor and low concentration of interleukin-4

Čolić, M. J., Jandrić, D., Stojić-Vukanić, Z., Antić‐Stanković, J., Popovič, P., Vasilijić, S., Milosavljević, P., & Balint, B. (2003) · Vojnosanitetski pregled · doi:10.2298/vsp0305531c · Cited by 16

Cross-Priming of T Cell Responses by Synthetic Microspheres Carrying a CD8+ T Cell Epitope Requires an Adjuvant Signal

Boisgérault, F., Rueda, P., Sun, C., Hervás‐Stubbs, S., Rojas, M., & Leclerc, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3432 · Cited by 16

Dendritic-cell-based anticancer vaccination: has it matured?

Fukao, T. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02198-1 · Cited by 16

Anti–HER-2/neuImmune Responses Are Induced before the Development of Clinical Tumors but Declined following Tumorigenesis in HER-2/neuTransgenic Mice

Takeuchi, N., Hiraoka, S.-I., Zhou, X., Nagafuku, M., Ono, S., Tsujimura, T., Nakazawa, M., Yura, Y., Hamaoka, T., & Fujiwara, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1081 · Cited by 16

Distinct features of dendritic cell-based immunotherapy as cancer vaccines

Lee, C., Lee, M., & Rhee, I. (2018) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2018.7.1.16 · Cited by 15

MUC1 in Cancer Immunotherapy — New Hope or Phantom Menace?

Syrkina, M. S., & Rubtsov, M. A. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919070083 · Cited by 15

Donor CD4 T Cells Are Critical in Allogeneic Stem Cell Transplantation against Murine Solid Tumor

Kamiryo, Y., Eto, M., Yamada, H., Yajima, T., Harano, M., Takeuchi, A., Tatsugami, K., Hamaguchi, M., Naito, S., & Yoshikai, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2517 · Cited by 15

Prospects for vaccine therapy for pancreatic cancer

Gaudernack, G. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.01.003 · Cited by 15

Dendritic Cells as Arbiters of Peritoneal Immune Responses

McCully, M. L., & Madrenas, J. (2006) · Peritoneal Dialysis International · doi:10.1177/089686080602600102 · Cited by 15

Antigen-presenting cells and tolerance induction

von Bubnoff, D., de la Salle, H., Wessendorf, J., Koch, S., Hanau, D., & Bieber, T. R. M. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.01150.x · Cited by 15

Lactation-Based Maternal Educational Immunity Crosses MHC Class I Barriers and Can Impart Th1 Immunity to Th2-Biased Recipients

Ghosh, M. K., Muller, H., & Walker, A. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601375 · Cited by 15

Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes

Mariani, C. L., Kouri, J. G., & Streit, W. J. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9137-x · Cited by 15

Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice

İzgi, K., İskender, B., Şakalar, Ç., Arslanhan, A., Saraymen, B., & Canatan, H. (2015) · European Cytokine Network · doi:10.1684/ecn.2015.0365 · Cited by 14

Cell-Mediated Immunity

Kamperschroer, C., Collinge, M., Heyen, J. R. R., Ji, C., O’Donnell, L. M., & Zhu, X. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64229-0 · Cited by 15

The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines

D’Aniello, A., Bene, A. D., Mottola, S., Mazzarella, V., Cutolo, R., Campagna, E., Maro, S. D., & Messere, A. (2024) · Journal of Peptide Science · doi:10.1002/psc.3596 · Cited by 14

Proteasomes, TAP, and Endoplasmic Reticulum-Associated Aminopeptidase Associated with Antigen Processing Control CD4+ Th Cell Responses by Regulating Indirect Presentation of MHC Class II-Restricted Cytoplasmic Antigens

Dragovic, S. M., Hill, T. M., Christianson, G. J., Kim, S., Elliott, T. J., Scott, D. M., Roopenian, D. C., Kaer, L. V., & Joyce, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100525 · Cited by 14

Endogenous and tumour-derived microRNAs regulate cross-presentation in dendritic cells and consequently cytotoxic T cell function

Kikete, S., Chu, X., Wang, L., & Bian, Y. (2016) · Cytotechnology · doi:10.1007/s10616-016-9975-0 · Cited by 16

Unique Transcompartmental Bridge: Antigen-Presenting Cells Sampling across Endothelial and Mucosal Barriers

Allen, F., Tong, A. A., & Huang, A. Y.-C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00231 · Cited by 16

Nucleic acid vaccines

McKenzie, B. S., Corbett, A. J., Brady, J. L., Dyer, C. M., Strugnell, R. A., Kent, S. J., Kramer, D. R., Boyle, J. S., & Lew, A. M. (2001) · Immunologic Research · doi:10.1385/ir:24:3:225 · Cited by 14

Immunothérapie du cancer : espoirs et réalités

Chouaı̈b, S., Hage, F. E., Benlalam, H., & Mami‐Chouaib, F. (2006) · médecine/sciences · doi:10.1051/medsci/20062289755 · Cited by 14

Transient gain of effector function by CD8+ T cells undergoing peripheral tolerance to high‐dose self‐antigen

Huang, X., & Yang, Y. (2004) · European Journal of Immunology · doi:10.1002/eji.200324734 · Cited by 14

Combined administration of the apoptin gene and poly (I:C) induces potent anti-tumor immune response and inhibits growth of mouse mammary tumors

Gupta, S. K., Tiwari, A. K., Gandham, R. K., & Sahoo, A. P. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.03.034 · Cited by 13

Identification of a bone marrow-derived CD8αα+ dendritic cell-like population in inflamed autoimmune target tissue with capability of inducing T cell apoptosis

Wu, J. G., Zhou, C., Robertson, J. M., Weng, C. C. Y., Meistrich, M. L., Tailor, R. C., & Lou, Y. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310133 · Cited by 13

Reducing or increasing β‐cell apoptosis without inflammation does not affect diabetes initiation in neonatal NOD mice

Carrington, E. M., Kos, C., Zhan, Y., Krishnamurthy, B., & Allison, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141476 · Cited by 13

Antigen‐specific impairment of adoptive T‐cell therapy against cancer: players, mechanisms, solutions and a hypothesis

Villadangos, J. A. (2016) · Immunological Reviews · doi:10.1111/imr.12433 · Cited by 13

Microneedle-mediated delivery of viral vectored vaccines

Zaric, M., Yus, B. I., Kalcheva, P., & Klavinskis, L. S. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1230096 · Cited by 13

Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective

Yolcu, E. S., Shirwan, H., & Askenasy, N. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0358 · Cited by 13

Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic Epitope and Subsequent Immunotherapy of Simian Virus 40 T Antigen-Induced Pancreatic Tumors

Otáhal, P., Knowles, B. B., Tevethia, S. S., & Schell, T. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6686 · Cited by 13

Selected climatic variables and blood pressure in Central European patients with chronic renal failure on haemodialysis treatment

Wystrychowski, G., Wystrychowski, W., Zukowska-Szczechowska, E., Tomaszewski, M., & Grzeszczak, W. (2005) · Blood Pressure · doi:10.1080/08037050510008850 · Cited by 13

Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy

Lu, Z., & Ghazizadeh, S. (2007) · Molecular Therapy · doi:10.1038/mt.sj.6300086 · Cited by 13

HIV-1 derived peptides fused to HBsAg affect its immunogenicity

Cervantes-Gonzalez, M., Kostrzak, A., Guétard, D., Pniewski, T., & Sala, M. (2009) · Virus Research · doi:10.1016/j.virusres.2009.09.007 · Cited by 13

ANTIGEN PROCESSING AND PRESENTATION TO T LYMPHOCYTES

Abbas, A. K., Lichtman, A. H., Pillai, S. S., & Baker, D. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-3123-9.50012-7 · Cited by 13

Antigen Presenting Properties of a Myeloid Dendritic-Like Cell in Murine Spleen

Hey, Y. Y., & O'Neill, H. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162358 · Cited by 13

Spatial And Temporal Expression of Herpes Simplex Virus Type 1 Amplicon-Encoded Genes: Implications for Their Use As Immunization Vectors

Santos, K., Simon, D. A. L., Conway, E., Bowers, W. J., Mitra, S., Foster, T. H., Lugade, A. A., Lord, E. M., Federoff, H. J., Dewhurst, S., et al. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.082 · Cited by 13

Cross-presentation by dendritic cells

Joffre, O. P., Segura, É., Savina, A., & Amigorena, S. (2012) · Nature reviews. Immunology · doi:10.1038/nri3254 · Cited by 1,764

Regulation of Antigen Presentation and Cross-Presentation in the Dendritic Cell Network: Facts, Hypothesis, and Immunological Implications

Wilson, N. S., & Villadangos, J. A. (2005) · Advances in immunology · doi:10.1016/s0065-2776(04)86007-3 · Cited by 181

Cross‐presentation: underlying mechanisms and role in immune surveillance

Rock, K. L., & Shen, L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00301.x · Cited by 469

The evolving biology of cross-presentation

Ohara, R. A., & MURPHY, K. M. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101711 · Cited by 37

Cross-Presentation of Antigens by Dendritic Cells

Heath, W. R., Carbone, F., & Belz, G. T. (2002) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v22.i5-6.50 · Cited by 70